中文

BAMEPHARM

DBM UPCOM Health Care
₫28,800
+0.00% 2026-08-28 · Close
AI Composite Signal
5.5 / 10
Neutral — 5-signal composite
Mkt Cap
46.6B
₫46.6B
Price Chart
What matters now

BAMEPHARM (DBM) is a company in Vietnam's Health Care sector, listed on UPCOM. The stock last traded at 28,800 VND, little changed on the session, giving a market capitalization of 46.6 billion VND.

Aveluro tracks 2 news items mentioning DBM, where recent coverage skews positive (100% of articles). The most recent catalyst was a dividend announcement event — "CTG, VCB Lead Cash Dividend Week: DBM Pays 35%, Banks Disburse Over VND 3,000B Each". Aveluro's composite model rates DBM 5.5/10 (Neutral), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Latest catalyst

CTG, VCB Lead Cash Dividend Week: DBM Pays 35%, Banks Disburse Over VND 3,000B Each

AI Signal Breakdown
Bearish Neutral Bullish
5.5 / 10
Neutral
Sentiment
+0.00
Impact
0.50
Momentum
-0.91
Fundamentals
+0.50
Volume
0.00
Sentiment 30% · Impact 20% · Momentum 20% · Fundamentals 15% · Volume 15%
News Sentiment
2
Articles Analyzed
Positive 2
Recent News
CTG, VCB Lead Cash Dividend Week: DBM Pays 35%, Banks Disburse Over VND 3,000B Each
Jul 18, 2026 Full Analysis Positive dividend announcement
CTG and VCB will each disburse over VND 3,000 billion in cash dividends at 4.5% rate, with ex-date July 23 and 24 respectively. DBM pays the highest rate at 35%, benefiting major shareholder TRA.
DBM (Dak Lak Pharmaceutical) announced a 35% cash dividend for 2025, with the record date on July 22 and payment on August 6. Major shareholder Traphaco (TRA) will receive about 3.9-4 billion VND.
Jul 09, 2026 CafeF - Doanh nghiệp Positive dividend announcement
Related Stocks — Health Care
AGP AGP AMP Armephaco AMV AMV APC APC BCP BCP BIO BIO CDP CDP CNC CNC CVN Vinam Group DAN DAN DBD DBD DBT DBT
Stock Analysis
Health Care stocks Vietnam DBM stock news Vietnam Dashboard Vietnam stocks for foreigners Foreign ownership limits

By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-08-28T16:04:48Z.